Intervention: mFOLFOX7 combined with Camrelizumab and apatinib
Found 4 matching trials
A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification
PHASE3
This study was designed to evaluate the effectiveness and safety of hepatic...